Professor Barbara Franke, Professor of Molecular Psychiatry, Departments of Human Genetics and Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen
Title: From finding genes to understanding biological mechanisms in neurodevelopmental psychiatric disorders
Monday 6 May, 2019
Lecture: 16 hrs. | Location: Jo Ritzenzaal: Oxfordlaan 55, Room 0.007
Drinks: 17 hrs. | Bandito Espresso
Barbara Franke holds the Chair of Molecular Psychiatry at Radboud University in Nijmegen, The Netherlands, where she is based at the Human Genetics and Psychiatry departments of the Radboud University Medical Center (Radboudumc). She is also a Principal Investigator at the Donders Institute for Brain, Cognition and Behaviour. At Radboudumc, she heads the Division of Genome Research and the Radboud Research Theme Neurodevelopmental Disorders. She is an elected member of the Royal Netherlands Academy of Arts and Sciences, the Royal Holland Society of Sciences and Humanities, and of Academia Europaea.
Educated in Giessen (Germany) and Utrecht (The Netherlands), she obtained her PhD in molecular signal-transduction in Utrecht before joining Radboud University. Her research is focused on understanding the genetic contribution to neurodevelopmental psychiatric disorders, especially ADHD and its comorbidities. Beyond gene-finding, she uses complementary approaches (bioinformatics, i-neurons, small animal models, neuroimaging genetics) to map biological pathways from gene to disease. She has obtained prestigious grants, including a personal Vici grant from the Dutch Organization of Scientific Research and several EU consortium grants. She coordinated the EU-FP7 Aggressotype consortium (2013-2018) on ADHD and aggression and the EU-H2020 European Training Network MiND (2014-2018) on autism-comorbidity in ADHD and currently leads work packages in two other EU-funded consortia (CoCA on ADHD comorbidity, Eat2beNICE on impulsive and compulsive behaviour and the role of nutrition and the gut microbiome). She founded and coordinates the International Multicentre persistent ADHD Collaboration (IMpACT) and the ECNP Network ‘ADHD across the Lifespan’, is a co-founder of imaging and genetics consortium ENIGMA, and is one of two leaders each of ENIGMA’s ADHD Working Group and the Psychiatric Genomics Consortium’s ADHD Working Group. In 2018, she was elected to the Board of Directors of the International Society for Psychiatric Genetics. Since 2019, she holds an honorary Adjunct Professorship at the Goethe University in Frankfurt am Main, Germany. Barbara Franke has (co-)authored over 400 peer reviewed publications and is on Clavirate’s list of the 1% most highly cited researchers worldwide.
Participation is free, but please note that registration is obligatory.